| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jin-Bo Gao | |
| Wen-Jia Shi | |||
| P2860 | cites work | Mutations of PIK3CA in gastric adenocarcinoma | Q21261219 |
| Global cancer statistics | Q22241238 | ||
| IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells | Q24310103 | ||
| Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy | Q24635408 | ||
| Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer | Q26778022 | ||
| Alterations of the TP53 gene in gastric and esophageal carcinogenesis | Q26866191 | ||
| Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer | Q27824834 | ||
| Relationship between p53 status and response to chemotherapy in patients with gastric cancer: a meta-analysis | Q27852996 | ||
| miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 | ||
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
| Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data | Q31044850 | ||
| Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells | Q33235983 | ||
| Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil | Q33274007 | ||
| Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells | Q33394070 | ||
| LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells | Q33655676 | ||
| Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB | Q33656653 | ||
| Distribution of basement membrane antigens in clinical gastric adenocarcinomas: an immunohistochemical study | Q33838435 | ||
| Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel | Q33903541 | ||
| Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer | Q34346821 | ||
| MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer | Q35051795 | ||
| Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells | Q35061283 | ||
| TP53 and gastric carcinoma: a review | Q35078746 | ||
| Drug resistance and the microenvironment: nature and nurture | Q35214616 | ||
| Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo | Q35290113 | ||
| Expression of P-glycoprotein mRNA in human gastric tumors | Q35574352 | ||
| Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer. | Q35615776 | ||
| Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop | Q35741610 | ||
| Immunohistochemical study of DNA topoisomerase II in human gastric disorders | Q35782052 | ||
| Palliative chemotherapy for advanced gastric cancer | Q35936039 | ||
| Activation of AKT kinases in cancer: implications for therapeutic targeting | Q36226730 | ||
| Chemotherapy versus support cancer treatment in advanced gastric cancer: a meta-analysis | Q36448352 | ||
| Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer | Q36450457 | ||
| miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer | Q36525110 | ||
| Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment | Q36614476 | ||
| Correlation between chemosensitivity to anticancer drugs and Bcl-2 expression in gastric cancer | Q37277833 | ||
| Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection | Q37352734 | ||
| The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer | Q37458683 | ||
| NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells | Q38358712 | ||
| Mitochondria-Judges and Executioners of Cell Death Sentences | Q38760561 | ||
| Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance | Q38877475 | ||
| IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance | Q38890440 | ||
| 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity | Q38967176 | ||
| Gastric cancer cell adhesion to laminin enhances acquired chemotherapeutic drug resistance mediated by MGr1-Ag/37LRP. | Q38993785 | ||
| Extracellular high mobility group box chromosomal protein 1 promotes drug resistance by increasing the expression of P‑glycoprotein expression in gastric adenocarcinoma cells | Q39022862 | ||
| rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy | Q39062896 | ||
| MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3. | Q39112720 | ||
| MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines | Q39115033 | ||
| miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. | Q39119238 | ||
| Bcl-2 gene silence enhances the sensitivity toward 5-Fluorouracil in gastric adenocarcinoma cells | Q39150533 | ||
| Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo | Q39172858 | ||
| Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel | Q39191770 | ||
| Mechanism of P-glycoprotein expression in the SGC7901 human gastric adenocarcinoma cell line induced by cyclooxygenase-2. | Q39295836 | ||
| Overexpression of interferon regulatory factor 1 enhances chemosensitivity to 5-fluorouracil in gastric cancer cells | Q39359345 | ||
| RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression | Q39507361 | ||
| Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer | Q39523783 | ||
| miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines | Q39738386 | ||
| Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells | Q39875032 | ||
| Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer | Q40063874 | ||
| Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death | Q40068228 | ||
| Reversal of multidrug resistance of gastric cancer cells by downregulation of Akt1 with Akt1 siRNA. | Q40169170 | ||
| Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference | Q40514557 | ||
| Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line | Q41055485 | ||
| Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin | Q41448414 | ||
| The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer | Q41890373 | ||
| Akt associates with nuclear factor kappaB and plays an important role in chemoresistance of gastric cancer cells | Q43049489 | ||
| Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer | Q43127559 | ||
| Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer. | Q43282233 | ||
| p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax. | Q44511919 | ||
| Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil | Q44679439 | ||
| Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer | Q45798976 | ||
| Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. | Q45940694 | ||
| TWEAK/Fn14 signaling mediates gastric cancer cell resistance to 5-fluorouracil via NF-κB activation | Q46890868 | ||
| Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. | Q51774995 | ||
| Activated Akt as an indicator of prognosis in gastric cancer. | Q53448904 | ||
| Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. | Q53469725 | ||
| The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy. | Q53981103 | ||
| High expression of multidrug resistance-1 (MDR-1) and its relationship with multiple prognostic factors in gastric carcinomas in patients in Turkey. | Q54082473 | ||
| Expression of P-glycoprotein influences resistance against anthracyclines in clinical gastric carcinomas. | Q54213578 | ||
| Expression of glutathione-S-transferases alpha and pi in gastric cancer: a correlation with cisplatin resistance. | Q54220328 | ||
| MDR1 gene expression and its clinical relevance in primary gastric carcinomas. | Q54248632 | ||
| Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma. | Q54338124 | ||
| Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis. | Q54513779 | ||
| HER-2/neu and TOPIIa expression in gastric cancer reflect disease severity. | Q54533786 | ||
| The prevalence of PIK3CA mutations in gastric and colon cancer. | Q54655912 | ||
| Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors | Q68920954 | ||
| P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer | Q73106648 | ||
| Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers | Q73499360 | ||
| Bax overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis | Q73548876 | ||
| Glutathione S-transferases and iododeoxyuridine labelling index during chemotherapy of gastric cancer | Q74118428 | ||
| Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy | Q79863813 | ||
| Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax | Q80856775 | ||
| Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer | Q82815102 | ||
| Tissue microarray analysis of topoisomerase IIalpha protein in gastric adenocarcinomas: histogenetic and prognostic implications | Q83963207 | ||
| Tumor chemosensitivity is correlated with expression of multidrug resistance associated factors in variously differentiated gastric carcinoma tissues | Q84928233 | ||
| Association between ABCB1 immunohistochemical expression and overall survival in gastric cancer patients | Q85210565 | ||
| Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer | Q86934356 | ||
| The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin | Q87659652 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 673-81 | |
| P577 | publication date | 2016-09-15 | |
| P1433 | published in | World journal of gastrointestinal oncology | Q27723329 |
| P1476 | title | Molecular mechanisms of chemoresistance in gastric cancer | |
| P478 | volume | 8 |
| Q64290144 | 2-Hydroxylated fatty acids as candidates of novel drugs to promote chemosensitivity of gastric cancer |
| Q91947760 | A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer |
| Q53686359 | A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models. |
| Q92343509 | Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells |
| Q91815478 | Benzyl Isothiocyanate Induces Apoptosis via Reactive Oxygen Species-Initiated Mitochondrial Dysfunction and DR4 and DR5 Death Receptor Activation in Gastric Adenocarcinoma Cells |
| Q55313144 | Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer. |
| Q88984924 | Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma |
| Q90022339 | Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma |
| Q64286913 | Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer |
| Q64261454 | Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis |
| Q47095382 | Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy |
| Q92995877 | Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines |
| Q100316263 | G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer |
| Q98611511 | H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis |
| Q50068814 | IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma |
| Q55513229 | KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. |
| Q58805925 | MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling |
| Q64953726 | Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer. |
| Q38796544 | Omega-3 Fatty Acid Grafted PAMAM-Paclitaxel Conjugate Exhibits Enhanced Anticancer Activity in Upper Gastrointestinal Cancer Cells |
| Q91711362 | Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases |
| Q55306139 | Optimizing miRNA-module diagnostic biomarkers of gastric carcinoma via integrated network analysis. |
| Q89823493 | PVT1 Long Non-coding RNA in Gastrointestinal Cancer |
| Q47403641 | Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer |
| Q90216839 | Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen |
| Q41488096 | The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2. |
| Q92608565 | The Zuo Jin Wan Formula increases chemosensitivity of human primary gastric cancer cells by AKT mediated mitochondrial translocation of cofilin-1 |
| Q64239549 | Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins |
| Q60921538 | Zuo Jin Wan Reverses DDP Resistance in Gastric Cancer through ROCK/PTEN/PI3K Signaling Pathway |
| Q49515320 | miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy |
Search more.